Exhibits DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Involved in several processes, including cellular response to calcium ion; cellular response to glucose stimulus; and dendrite morphogenesis. Localizes to nucleus. Human ortholog(s) of this gene implicated in dilated cardiomyopathy. Orthologous to human MEF2A (myocyte enhancer factor 2A); INTERACTS WITH 1,2-dimethylhydrazine; 17alpha-ethynylestradiol; 2-amino-2-deoxy-D-glucopyranose.
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MEF2A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MEF2A mRNA
[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MEF2A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MEF2A mRNA
Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A mRNA], Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A protein]
Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A mRNA], Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A protein]
Metoprolol inhibits the reaction [[[PPARGC1A protein results in increased expression of MEF2A mRNA] co-treated with [PPARGC1A protein results in increased expression of PPARA mRNA]] results in increased expression of CPT1B protein], Metoprolol inhibits the reaction [MEF2A protein binds to CPT1B promoter]
MEF2A protein promotes the reaction [Oxytocin results in increased expression of KLF4 mRNA], MEF2A protein promotes the reaction [Oxytocin results in increased expression of KLF4 protein]
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of MEF2A mRNA
ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]
ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of MEF2A mRNA
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin